| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161124C Sulfacted oilgosacharides having anticoagulant/antithrombotic activity |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774107 Protein for blocking platelet adhesion |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | US6773414 Device and method for dispensing at least two mutually reactive components |
| 08/07/2004 | CA2457105A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065418A1 Anti-pci neutralizing antibody |
| 08/05/2004 | WO2004065369A1 Carboxamide derivatives and their use as factor xa inhibitors |
| 08/05/2004 | WO2004064764A2 Substituted alkyl amido piperidines |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004029192A3 Producing method of tien hsien liquid |
| 08/05/2004 | WO2004024875A3 Mammalian megakaryocyte progenitor cell |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | US20040152779 Bicyclic amino acids as pharmaceutical agents |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152751 Viricides; suppress lymphocytes; aids therapy; antiinflammatory agents |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152663 Dissolving an amphiphilic heparin derivative comprising heparin covalently bonded to a hydrophobic agent selected from bile acids, sterols, alkanoic acids, and mixtures thereof in a water phase; dispersing in organic phase; drying emulsion |
| 08/05/2004 | US20040152628 Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | US20040151779 suspending an active agent-containing powder with active agent hydration less than about 10% in at least one anhydrous, aprotic, hydrophobic, non-polar, low-reactivity vehicle; useful to delivery to an animal for sustained release for long term treatment |
| 08/05/2004 | US20040151776 Novel compositions |
| 08/05/2004 | US20040151739 transporter and fusion protein contains a binding domain for the transporter and a modulation domain for the covalent modification of small GTP-binding proteins; transporter permits the uptake of the fusion protein in a target cell |
| 08/05/2004 | US20040151692 administering a substance that can activate CD163 to stimulate the growth, proliferation, differentiation and/or mobilization of a stem cell, e.g., a substance that binds CD163 includes antibodies and CD163 ligands. |
| 08/05/2004 | US20040151667 Internal image antibodies for optical imaging and therapy |
| 08/05/2004 | CA2514100A1 Carboxamide derivatives and the use thereof as factor xa inhibitors |
| 08/05/2004 | CA2509456A1 Substituted alkyl amido piperidines |
| 08/04/2004 | EP1443041A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 08/04/2004 | EP1442747A1 Superoxide dismutase and mimetics thereof |
| 08/04/2004 | EP1442743A1 Medicament comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin converting enzyme (ACE) for use in the treatment of neurodegenerative diseases |
| 08/04/2004 | EP1442143A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/04/2004 | EP1442125A2 Chimeric viral vectors for gene therapy |
| 08/04/2004 | EP1442115A2 METHODS OF ISOLATION, EXPANSION AND DIFFERENTIATION OF FETAL STEM CELLS FROM CHORIONIC VILLUS, AMNIOTIC FLUID, AND PLACENTA AND THERAPEUTIC USES THEREOF |
| 08/04/2004 | EP1442040A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442026A1 Triazole derivatives as cyclooxygenase (cox) inhibitors |
| 08/04/2004 | EP1442024A1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 08/04/2004 | EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/04/2004 | EP1442017A1 Preparation of benzosuberonylpiperidine compounds |
| 08/04/2004 | EP1441800A2 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 08/04/2004 | EP1441771A1 Aqueous sustained-release formulations of proteins |
| 08/04/2004 | EP1441762A1 Rsv gene expression vaccine |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441732A2 Thiazole derivative and pharmaceutical use thereof |
| 08/04/2004 | EP1441726A1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441723A1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1441697A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 08/04/2004 | EP1441667A1 Improved endoprosthetic device |
| 08/04/2004 | EP1294380B1 A method for treating septic shock |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | EP1140903B1 Aromatic amides |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP1070714B1 Amidine compounds |
| 08/04/2004 | EP1034001B1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/04/2004 | EP0996462B1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins |
| 08/04/2004 | EP0690671B1 Method and apparatus for encapsulation of biologically-active substances in cells |
| 08/04/2004 | CN1518598A Serpin in Bifidobacteria |
| 08/04/2004 | CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 08/04/2004 | CN1518557A Novel 5-thio-beta-D-xylopyranoside derivatives, preparation meethod thereof, pharmaceutical compositions containing same and the therapeutic use thereof |
| 08/04/2004 | CN1518553A Beta-substituted befa-aminoethyl. phosphonates compound |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518452A Oral delivery of macromolecules |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1517365A Bifunctional chimeric profein possessing inhibiting leucocyte function and thrombin activity |
| 08/04/2004 | CN1517126A Drug compastion with thrombolysis, anti-inflammatory and cell protective function |
| 08/04/2004 | CN1517096A Application of bamboo leaf flavone in preparation of medicine |
| 08/04/2004 | CN1160357C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160333C Ester of pipperidinemethanol and their use as prodrugs of the 5HT2A receptor antagonist MDL 110,907 |
| 08/04/2004 | CN1160323C New benzenesulfonylamine derivatives, process for preparating them and pharmaceutical compositions containing them |
| 08/04/2004 | CN1159984C Prophylactic dietary supplement based on milk |
| 08/03/2004 | US6770746 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 08/03/2004 | US6770660 Method for inhibiting platelet aggregation |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770634 Stimulate mammalian coronary vasodilatation for therapeutic purposes and imaging the heart |
| 08/03/2004 | US6770628 Hematopoietic stimulation |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770620 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 08/03/2004 | US6770478 Erythrocytic cells and method for preserving cells |
| 08/03/2004 | US6770292 Pharmaceutical compositions for oral administration |
| 08/03/2004 | US6770260 Mammal model contains a decreased level of endogenous macrophages sufficient to reduce depletion of non-autologous hematopoietic cells, achieved by administering an effective amount of dichloromethylene diphosphonate |
| 08/03/2004 | US6770148 Peritoneal dialysis solution containing modified icodextrins |
| 08/03/2004 | CA2127542C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063212A2 Organic compounds with biological action as thrombin inhibitors and use therof |